-
December 27, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner Pfizer Inc. (PFE) received some encouraging news with the ...
-
December 26, 2012
Pfizer (PFE) recently entered into two deals. While one deal was signed with biopharma company Halozyme ...
-
December 26, 2012
French pharmaceutical company, Sanofi's (SNY) Animal Health division, Merial, recently announced that it will ...
-
December 26, 2012
Merck (MRK) recently announced disappointing results from a long-term safety study of cholesterol management drug, ...
-
December 21, 2012
GlaxoSmithKline (GSK) and partner Amicus Therapeutics (FOLD) recently presented disappointing top-line six-month ...
-
December 20, 2012
Novo Nordisk (NVO) recently completed a phase IIIa study on IDegLira, which is a combination of Tresiba (insulin ...
-
December 20, 2012
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced that they have submitted a marketing ...
-
December 20, 2012
Good news flowed in at AstraZeneca (AZN) with the American College of Cardiology Foundation (ACCF) and American ...
-
December 19, 2012
Merck (MRK) is collaborating with GE Healthcare for the use of an investigational positron emission tomography (PET) ...
-
December 18, 2012
GlaxoSmithKline (GSK) recently announced that its inhalational anthrax candidate, raxibacumab, has received US Food ...
-
December 17, 2012
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not ...
-
December 17, 2012
The US Food and Drug Administration ("FDA") recently approved Novartis' (NVS) Signifor (pasireotide) to treat adults ...
-
December 17, 2012
Eli Lilly and Company (LLY) recently announced its decision to scrap one of three pivotal phase III studies being ...
-
December 14, 2012
Janssen Research & Development, LLC, a part of the Johnson & Johnson (JNJ) family of companies, recently announced ...
-
December 13, 2012
Sanofi (SNY) recently announced positive results from a phase II trial evaluating the efficacy of its hematology ...
-
December 12, 2012
Bristol-Myers Squibb Company (BMY) and partner Abbott Laboratories (ABT) recently presented data on their oncology ...
-
November 29, 2012
Novo Nordisk (NVO) recently announced data from the post-hoc analysis of two phase III b studies on Victoza ...
-
November 23, 2012
The market is having a good day so far: the Nasdaq has risen 1.3%; the S&P 500 has moved up 1%; and the Dow is ...
-
November 23, 2012
The market is currently up, with the Nasdaq moving up 1.3%, the S&P 500 rising 1%, and the Dow increasing 1%. ...
-
November 21, 2012
Sanofi (SNY) recently announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for ...
